0000911916-17-000028.txt : 20170104 0000911916-17-000028.hdr.sgml : 20170104 20170104162534 ACCESSION NUMBER: 0000911916-17-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kuca Bernice CENTRAL INDEX KEY: 0001639976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 17505828 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-01-03 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001639976 Kuca Bernice C/O COLUCID PHARMACEUTICALS, INC. 222 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 Head,Clin. and Reg. Operations Common Stock 2017-01-03 4 S 0 772 36.25 D 40086 D Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Kuca on August 15, 2016. One purpose of the plan is to sell shares of common stock acquired under the CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan. /s/ Christine G. Long, Attorney-in-Fact for Bernice Kuca (power of attorney previously filed) 2017-01-04